Skip to Content
Merck
CN

45318

Allidochlor

PESTANAL®, analytical standard

Synonym(s):

N,N-Diallyl-2-chloroacetamide

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C8H12ClNO
CAS Number:
Molecular Weight:
173.64
EC Number:
202-270-7
UNSPSC Code:
41116107
PubChem Substance ID:
Beilstein/REAXYS Number:
1761616
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

grade

analytical standard

product line

PESTANAL®

shelf life

limited shelf life, expiry date on the label

technique(s)

HPLC: suitable, gas chromatography (GC): suitable

application(s)

agriculture
environmental

format

neat

SMILES string

ClCC(=O)N(CC=C)CC=C

InChI

1S/C8H12ClNO/c1-3-5-10(6-4-2)8(11)7-9/h3-4H,1-2,5-7H2

InChI key

MDBGGTQNNUOQRC-UHFFFAOYSA-N

Application

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

Legal Information

PESTANAL is a registered trademark of Merck KGaA, Darmstadt, Germany

Regulatory Information

农药列管产品

This item has


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

George L Tipoe et al.
Respiratory physiology & neurobiology, 138(2-3), 143-154 (2003-11-12)
We examined the protein expression and localization of HIF-1alpha, VEGF, VEGF receptors in the carotid body (CB) of rats breathing 10% inspired oxygen for up to 4 weeks. The immunoreactivity (IR) of HIF-1alpha was distributed numerously in the nuclei of
[Hepatocarcinogenesis with chemicals including mycotoxins].
K Okita
Nihon rinsho. Japanese journal of clinical medicine, 59 Suppl 6, 76-82 (2002-01-05)
Richard Foon et al.
International urogynecology journal and pelvic floor dysfunction, 19(12), 1697-1706 (2008-07-09)
The objective of this study is to assess the objective recurrence and complications of adjuvant materials in the treatment of anterior vaginal wall prolapse. The inclusion criteria were randomised controlled trials (RCTs) using adjuvant materials versus standard surgery for anterior

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service